Covid-19 jab could be ready in two years. BioNTech in Germany had already been working on a drug to fight cancer when the pandemic hit.
By rapidly developing a vaccine for coronavirus with Pfizer, massive orders helped fund BioNTech's work on an effective cancer vaccine.It will use the same science behind the Covid-19 vaccine to tackle cancerous tumours.
A messenger RNA, which codes for a disease-specific antigen, will carry instructions into the human body for making proteins that prime it to attack a virus, New York Post reports.
Read more on dailystar.co.uk